Multi-omics analysis of kidney renal cell carcinoma in silico with preliminary in vivo validation - Top-Institutions - MDSpire

Multi-omics analysis of kidney renal cell carcinoma in silico with preliminary in vivo validation

  • By

  • Tingyu Su

  • Fan Jiang

  • Jianjun Gao

  • Xiubin Li

  • Hongmei Cheng

  • Yang Wang

  • June 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University Medical Center Hamburg-Eppendorf
    University Medical Center Hamburg-Eppendorf

    Hamburg, Germany

    Key Differentiators

    • Oncology
    • Urology

  • #2

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, New York

    Key Differentiators

    • Oncology

  • #3

    Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo

    Buffalo, New York

    Key Differentiators

    • Oncology

  • #4

    Translational Genomics Research Institute
    Translational Genomics Research Institute

    Phoenix, Arizona

    Key Differentiators

    • Oncology
    • Genomics

  • #5

    City of Hope Comprehensive Cancer Center
    City of Hope Comprehensive Cancer Center

    Duarte, California

    Key Differentiators

    • Oncology

Original Source(s)

Multi-omics analysis of kidney renal cell carcinoma in silico with preliminary in vivo validation

  • by Tingyu Su, Fan Jiang, Jianjun Gao, Xiubin Li, Hongmei Cheng, Yang Wang

  • June 8, 2026

Related Content

NAT10 as a central node in cancer biology: integrating epitranscriptomic regulation, metabolic reprogramming, and immune modulation

TIFA: a signaling hub linking inflammation, innate immunity, and human disease

Multiple primary head and neck cancers: a scenario-based framework for diagnosis and modern multidisciplinary management